login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NEMAURA MEDICAL INC (NMRD) Stock News
USA
- NASDAQ:NMRD -
US6404422080
-
Common Stock
0.1053
USD
-0.02 (-17.8%)
Last: 1/4/2024, 8:15:19 PM
0.12
USD
+0.01 (+13.96%)
After Hours:
1/4/2024, 8:15:19 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NMRD Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
FBIO
ALZN
VANI
Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
2 years ago - By: Benzinga
- Mentions:
VYGR
ATXI
ALLO
APLT
...
12 Health Care Stocks Moving In Thursday's After-Market Session
2 years ago - By: Nemaura Medical, Inc
Important Update on Listing Status and Strategic Direction
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
2 years ago - By: Seeking Alpha
Nemaura Medical secures $10M non-dilutive credit facility (NASDAQ:NMRD)
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
2 years ago - By: Nemaura Medical, Inc
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
2 years ago - By: InvestorPlace
- Mentions:
AGRI
MBRX
LIFW
TKAT
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
2 years ago - By: Seeking Alpha
Nemaura Medical says compliance regain with Nasdaq rules not expected (NASDAQ:NMRD)
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
2 years ago - By: Nemaura Medical, Inc
Nemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results
Please enable JavaScript to continue using this application.